Generics
Cipla's AB-rated Ventolin HFA generic receives US FDA approval
24 April 2026 - Indian pharmaceutical company Cipla Limited (BSE:500087) (NSE:CIPLA-EQ) and its US subsidiary Cipla USA Inc announced on Thursday that the US Food and Drug Administration (FDA) has giv...
Newbury Pharmaceuticals secures first Scandinavian approval for palbociclib generic
17 April 2026 - Swedish pharmaceutical company Newbury Pharmaceuticals AB (STO:NEWBRY) announced on Friday that it has obtained Marketing Authorization in Denmark for Palbociclib Newbury tablets, mark...
Apotex's generic Ozempic (Semaglutide Injection) receives US FDA tentative approval
13 April 2026 - Canadian pharmaceutical company Apotex Inc announced on Friday that its US subsidiary Apotex Corp has received the first US Food and Drug Administration (FDA) tentative approval for it...
DifGen and Apotex report FDA approval of generic Nintedanib Soft Gel Capsules
10 April 2026 - DifGen Pharmaceuticals LLC, a US-based specialty generic pharmaceutical company, announced on Thursday that its Canadian partner, Apotex Inc, has received final approval from the US Fo...
Dexcel Pharma's Nintedanib Capsules approved for US launch
8 April 2026 - Dexcel Pharma USA, a subsidiary of Israeli pharmaceutical company Dexcel Pharma, announced on Tuesday that it has received final approval from the US Food and Drug Administration (FDA) ...
Upsher-Smith launches generic version of Ciprodex ear drop suspension
7 April 2026 - US pharmaceutical company Upsher-Smith Laboratories LLC, a subsidiary of Taiwan-based Bora Pharmaceuticals Co Ltd (TW:6472) (OTCQX:BORAY) announced on Monday the launch of Ciprofloxacin...